publication date: Aug. 3, 2010
In this issue: Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand. Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics. In Multi-Site Phase I Studies, No Investigator Sees All Toxicities. Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.